SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-16-128827
Filing Date
2016-06-22
Accepted
2016-06-22 16:01:39
Documents
3
Period of Report
2016-06-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a16-13827_18k.htm 8-K 24967
2 EX-99.1 a16-13827_1ex99d1.htm EX-99.1 12488
3 GRAPHIC g138271mmi001.jpg GRAPHIC 4039
  Complete submission text file 0001104659-16-128827.txt   44414
Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35921 | Film No.: 161726629
SIC: 2834 Pharmaceutical Preparations